The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes ...

Following the devastating fires that swept through Los Angeles in January, concerns are on the rise about the long-term health impacts of smoke inhalation.

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.

One of the key changes proposed is the establishment of “cumulative impact” scores. They would represent the totality of ...

but most drugs in development represent approaches based on a better understanding of the underlying inflammatory and immune mechanisms of asthma. The currently available inhaled corticosteroids ...

In an age where respiratory health is becoming increasingly important, the demand for practical solutions to breathing issues ...

Breastfeeding, also known as chestfeeding, provides immense benefits to the infant, including protection against leukemia, or ...

Asthma is a clinical diagnosis based on symptoms and tests of pulmonary function, but a variety of pathophysiologic mechanisms lead to the final common pathway, which is characterized by variable ...